4Front Ventures Corp. (FFNTF)
OTCMKTS · Delayed Price · Currency is USD
0.0009
0.00 (0.00%)
Aug 15, 2025, 9:38 AM EDT
4Front Ventures Market Cap
4Front Ventures has a market cap or net worth of $3.30 million as of August 18, 2025. Its market cap has decreased by -95.93% in one year.
Market Cap
3.30M
Enterprise Value
225.86M
Revenue
75.61M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since August 6, 2019, 4Front Ventures's market cap has decreased from 155.73M to 3.30M, a decrease of -97.88%. That is a compound annual growth rate of -48.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2025 | 3.30M | -79.27% |
| Dec 31, 2024 | 15.90M | -75.87% |
| Dec 29, 2023 | 65.91M | -55.19% |
| Dec 30, 2022 | 147.08M | -75.33% |
| Dec 31, 2021 | 596.24M | 48.30% |
| Dec 31, 2020 | 402.05M | 66.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 6, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 781.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 580.89M |
| Glass House Brands | 567.91M |
| American Oncology Network | 379.23M |
| Northwest Biotherapeutics | 363.17M |
| CytoDyn | 344.75M |